Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v3-EN
Language English English
Date Updated 2023-03-25 2023-01-09
Drug Identification Number 02321106 02321106
Brand name PRISTIQ PRISTIQ
Common or Proper name PRISTIQ PRISTIQ
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients DESVENLAFAXINE DESVENLAFAXINE
Strength(s) 100MG 100MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30's 30's
ATC code N06AX N06AX
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2023-02-01 2023-01-24
Actual start date 2023-02-01
Estimated end date 2023-03-27 2023-03-27
Actual end date 2023-03-24
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Limited inventory available and on preventative allocation.
Health Canada comments